Alerta

一种单原子铁掺杂碳量子点及制备方法与应用

Resumen de: CN122850225A

本发明提供了一种单原子铁掺杂碳量子点及制备方法与应用，以水为溶剂，以乙二胺四乙酸为螯合剂，以六水合三氯化铁为铁源，通过水热反应得到单原子铁掺杂碳量子点；六水合三氯化铁中的铁与乙二胺四乙酸的摩尔比为1:2。本发明制得单原子铁掺杂碳量子点尺寸小、水溶性极佳，且表现出高效的类过氧化物酶活性和化学动力学肿瘤治疗效果。

一种益母草碱碳点及其制备方法和应用

Resumen de: CN122855069A

本发明公开了一种益母草碱碳点及其制备方法和应用，属于材料领域。本发明请求保护一种益母草碱碳点，以益母草碱为原料，经水热法制得。该益母草碱碳点为一种粒径分布均匀的球形纳米颗粒，且存在明显的晶格条纹。活性测试表明，该益母草碱碳点不仅可以有效缓解烟雾暴露导致的肺损伤，还可以有效抑制金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌（其中，耐甲氧西林金黄色葡萄球菌是一种全球广泛流行的经典超级细菌）。因此，该益母草碱碳点具有开发成预防或/和治疗肺损伤、抗菌药品的前景。本发明还提供了该益母草碱碳点的制备方法，步骤简单，适合工业生产。

CARBON QUANTUM DOTS (CQDS) AND METHOD FOR SYNTHESIZING THE SAME THEREOF FOR LUBRICATION AND PHOTOLUMINESCENCE

Resumen de: WO2026202932A1

The present invention discloses a novel, cost-effective, and scalable method for synthesizing Carbon Quantum Dots (CQDs) with applications in lubrication and solar energy conversion. The CQDs are produced via a hydrothermal process using organic precursors with hydroxyl (- OH) groups, followed by acidification and thermal treatment. The synthesized CQDs, with a 5 size range of 2-5 nm, exhibit strong photoluminescence, high dispersion stability, and superior tribological properties. CQDs are incorporated into base lubricants to form nanolubricants, which reduce the coefficient of friction (CoF) by 48-50%, improving machinery efficiency. Additionally, CQDs are dispersed in organic solvents and encapsulated in solar PV modules, enhancing photon down-conversion and increasing solar efficiency. The invention provides an 0 eco-friendly alternative to conventional CQD synthesis, ensuring high performance, chemical stability, and industrial scalability across automotive, renewable energy, and nanotechnology sectors.

CASIMIR-EFFECT BASED TUNNEL TRANSISTOR UTILIZING GRAPHENE

Resumen de: US20260304851A1

A quantum device includes an actuator including a graphene material and having a proximal end mounted to an actuator anchor; an electrode disposed on a distal end of the actuator; a quantum dot, configured to localize a single electron, the quantum dot and the electrode disposed within a common vacuum to define a tunneling gap; and a quantum dot anchor, comprising the graphene material, disposed in a same plane as the quantum dot relative to the electrode. The quantum device may include a modulator configured to emit electromagnetic signaling within a particular frequency range. The graphene material is tuned to increase a Casimir force between the electrode and the quantum dot anchor in response to the electromagnetic signaling. The increased Casimir force causes the actuator to deform to bring the electrode within an electron tunneling range of the quantum dot, or lowers a tunneling barrier on a static electrode.

RETINA IMAGE FORMATION ENHANCEMENT THROUGH ACTIVE NANOPARTICLE-BASED PHOTORECEPTORS

Resumen de: US20260295257A1

0000 An artificial photoreceptors (APR) includes a nano-dielectric core, a plurality of optical dipoles each optical dipole attached to the surface of the nano-dielectric core, and each optical dipole includes a first nano-particle configured to generate a positive voltage when receiving a light pulse having a predetermined wavelength, and a second nano-particle configured to generate a negative voltage when receiving a light pulse having the predetermined wavelength, wherein i) a plurality of a first set of the first and second nano-particles of the plurality of optical dipoles cancel each other's voltages such that a plurality of APRs only generate voltages at locations corresponding to edge-detected signals representing edges of an object; or ii) a plurality of a second set of the first and second nano-particles of the plurality of optical dipoles generate positive and negative voltages to sequentially generate responses for biological receptors.

METHODS FOR MAKING AND USING CURRENT COLLECTORS

Resumen de: WO2026206402A1

Disclosed herein are methods for making current collectors for battery applications. In one embodiment, method for making a current collector includes: mixing first metal particles, a second metal particles, and a carrier fluid to make an ink, where the first metal particles are selected from silicon, zirconium, magnesium, silver, gold, platinum, indium, where the first metal particles have an average cross-sectional diameter from about 3 nm to about 100 nm, where the second metal particle is selected from copper, aluminum, nickel, titanium, and steel, where the second metal particles have an average cross-sectional diameter from about 5 μm to about 50 μm, and where the carrier fluid is selected from water, toluene, ethanol, isopropanol, acetone, hexane, N-methyl-2- pyrrolidone, acetonitrile, dimethyl sulfoxide, dimethylformamide, tetrahydrofuran, and N,Ndimethylformamide; printing, by direct ink writing, one or more layers of the ink on one or more substrates using a printing nozzle to make a current collector.

AG2SE AND AG2S QUANTUM DOTS (QDS) OR NANOCRYSTALS TO PRODUCE THE HIGH-SPEED PHOTODETECTORS

Resumen de: WO2026199080A1

Method to synthesize the Ag2Se and Ag2S quantum dots and develop close to 200 % photogeneration efficiency solution-processed high-speed IR photodetectors, which is due to the multiple electron generation effect. In particular, disclosed herein are methods for synthesizing silver chalcogenide quantum dots, specifically Ag₂Se and Ag₂S, for application in high-speed photodetectors. The synthesis involves a solution-phase approach conducted at controlled temperatures to preserve desirable semiconductor phases and to achieve uniform quantum dot morphology and composition. These quantum dots are integrated into photoconductive device structures that exhibit enhanced photoresponse in the short-wavelength infrared (SWIR) region. The photodetectors demonstrate rapid response times and high efficiency, making them suitable for applications such as optical communication, medical imaging, remote sensing, and quantum optics. The disclosed methods offer an environmentally benign and scalable alternative to conventional high-speed photodetector fabrication techniques.

COMPOSITIONS AND METHODS FOR THE SYNTHESIS OF VAULTS

Resumen de: WO2026207364A1

Compositions and methods for the in vitro synthesis of vaults are disclosed.

GLUCONIC ACID-COATED SELENIUM NANOPARTICLES AND MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SELENIUM NANOPARTICLE AND APPLICATIONS THEREOF

Resumen de: US20260294824A1

The present invention provides a gluconic acid-coated selenium nanoparticle (GA-SeNP), which comprises a selenium nanoparticle and gluconic acid, wherein the gluconic acid is coated on the selenium nanoparticle to form a core-shell structure. GA-SeNPs can repolarize M2 macrophages into M1 macrophages and induce apoptosis of cancer cells through the generation of reactive oxygen species, thereby serving as the medicine for cancer treatment. A manufacturing method thereof is also provided.

A HIGH-VOLTAGE TRANSPARENT TRIBOELECTRIC NANOGENERATOR

Resumen de: WO2026202937A1

A high voltage transparent triboelectric nanogenerator (TENG) comprising a) a lower substrate, said lower substrate b) an upper substrate, said upper substrate c) four stainless steel springs located at the corners of lower substrate. A tremendous improvement in the output performance of flexible-transparent triboelectric nanogenerator from 280 Vpp to > 3 kVpp and 2 µApp to > 35 µApp with an instantaneous peak power density of > 20 W/m2 is achieved after incorporating the enhancement techniques. Further, the device was redesigned to a spring assisted rigid form and scaled up to 16 cm2 which generates an output voltage of > 4 kVpp, and a short circuit current of > 45 µApp, under an applied force of 20 N. Furthermore, the spring assisted rigid triboelectric nanogenerator is integrated with a footwear, enabling the scavenging of biomechanical energy, opening up exciting possibilities for self-powered wearable electronics and for powering sensor networks.

A MULTI-FUNCTIONAL SOLID NANOPARTICLE SYSTEM FOR TREATING OCULAR DISEASE

Resumen de: WO2026207117A1

Compositions and methods are provided for glaucoma or ocular hypertension therapy. The compositions of the disclosure include solid drug nanoparticles comprised of at least two active agents: (i) a neuroprotectant, and (ii) a β adrenergic blocker. In some embodiments the neuroprotectant is maprotiline. In some embodiments the β adrenergic blocker is betaxolol. The combination of agents in nanoparticle form is shown to have synergistic benefits in the treatment of ocular disease.

QUANTUM DOT-NANOCELLULOSE COMPOSITE OPTOELECTRONIC THIN FILM AND PREPARATION METHOD THEREFOR

Resumen de: WO2026199955A1

The present invention belongs to the technical field of optoelectronic functional materials, and specifically relates to a quantum dot-nanocellulose composite optoelectronic thin film and a preparation method therefor. The preparation method comprises the following steps: using quantum dots as a light-emitting material and cellulose nanocrystals as a stress buffer and optical scattering enhancer, and mixing same to prepare a composite solution; and depositing the composite solution on a substrate, and introducing the cellulose nanocrystals into a quantum dot thin film by means of the distribution, via the cellulose nanocrystals, of the stress generated by quantum dot packing and shrinkage during the process of film formation and the optical scattering capability of the cellulose nanocrystals, so as to obtain a quantum dot-nanocellulose composite optoelectronic thin film. In the present invention, by means of the introduction of cellulose nanocrystals into the quantum dot thin film, stress buffering and optical scattering enhancement functions are provided; therefore, the structural stability and optical performance of the thin film are improved, thereby solving the problems of proneness to cracking and the low light absorption efficiency of the quantum dot thin film.

MAGNETIC MATERIAL, MAGNETIC FLUID, STANDARD SAMPLE FOR PARTICLE SIZE DISTRIBUTION MEASUREMENT, METHOD FOR PRODUCING A MAGNETIC MATERIAL AND METHOD FOR PRODUCING A MAGNETIC FLUID

Resumen de: US20260302021A1

To provide a magnetic material, magnetic fluid, standard sample for particle size distribution measurement, method for producing a magnetic material and method for producing a magnetic fluid that solves the storage and safety issues of polar organic solvent-based magnetic fluids and effectively suppresses the generation of secondary particles of magnetic particles in magnetic fluids even when a polar organic solvent is added to a magnetic material obtained by removing the dispersion media from a first magnetic fluid to form a second magnetic fluid. A magnetic material comprising magnetic particles having an average particle size of 10 to 50 nm, a saturated fatty acid or a salt thereof, or an unsaturated fatty acid or a salt thereof, having 10 to 24 carbon atoms, and an alkoxylate formed by addition of an alkylene oxide having 2 to 4 carbon atoms to an alcohol having 1 to 3 carbon atoms.

LITHIUM IRON PHOSPHATE POSITIVE ELECTRODE MATERIAL AND PREPARATION METHOD THEREFOR, AND LITHIUM BATTERY

Resumen de: WO2026199909A1

The present disclosure relates to the technical field of lithium-ion batteries. Disclosed are a lithium iron phosphate positive electrode material and a preparation method therefor, and a lithium battery. In the present disclosure, by using a specific method for testing the pressing index of the lithium iron phosphate positive electrode material, the pressing index satisfies a specific range; moreover, the average circularity of larger particles within the range of Dv50-Dv100 satisfies a suitable range. Such a lithium iron phosphate positive electrode material has greater particle movement capability, and the particles can move and rearrange at a faster rate during pressing, thereby facilitating obtaining a positive electrode sheet having a high compaction density and improving the charge-discharge capacity of a battery, and also facilitating avoiding particle breakage under pressure, such that the lithium iron phosphate positive electrode material has a good pressure resistance capability. By using the lithium iron phosphate positive electrode material provided in the present disclosure, the lithium battery has a relatively high energy density and capacity retention rate.

AN INTELLIGENT CHARGE SWITCHABLE POLYMER-LIPID HYBRID SYSTEM FOR IN VIVO DELIVERY OF MOLECULES INCLUDING RNAs

Resumen de: US20260294830A1

Among other things, in general, polymer-lipid nanoparticles (PLNPs) are disclosed that have charge switching properties which allow for efficient release of payloads in the pH environment of the endosome. PLNPs and methods of manufacture thereof are disclosed for charge switchable PLNPs having an anionic polymeric shell surrounding ionizable cationic lipids (also potentially including helper lipids and cholesterol) that are in complex with a cargo (such as, in a non-limiting example, therapeutically useful nucleic acids).

CORE-SHELL PARTICLES AND METHODS THEREOF

Resumen de: US20260298918A1

The present disclosure relates to core-shell particles, in which a particle can include a core having one or more color centers and a shell disposed around the core. Also provided herein are methods of preparing such particles, devices including one or more core-shell particles, as well as methods for detecting a target using such devices.

CONDUCTIVE DISPERSION AND PRODUCTION METHOD THEREFOR

Resumen de: US20260296892A1

0000 A conductive dispersion includes a conductive carbon material, a liquid component, and a resin component dissolved in the liquid component. The conductive carbon material is dispersed in the liquid component. The conductive carbon material is in a fibrous form or in an aggregate form. The resin component includes a first component and a second component. The weight-average molecular weight Mw1 of the first component and the weight-average molecular weight Mw2 of the second component satisfy Mw1

CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION, AND DISPLAY DEVICE INCLUDING THE CURED LAYER

Resumen de: US20260299177A1

0000 Provided are a curable composition including (A) quantum dots including a structural unit represented by Chemical Formula 1; and (B) a polymerizable compound, a cured layer produced using the curable composition, and a display device including the cured layer. 0000 0000 In Chemical Formula 1, each substituent is as defined in the specification.

SECONDARY STRUCTURE OF CARBON NANOTUBES AND SULFUR-CARBON COMPOSITE COMPRISING THE SAME

Resumen de: US20260296891A1

0000 An aspect of the present disclosure relates to a carbon composite for use in a positive electrode of a lithium-sulfur battery, comprising a secondary structure of carbon nanotubes which is agglomerates of carbon nanotubes, wherein the secondary structure has a flower-like structure comprising a spherical core and at least one amorphous flake on a surface of the spherical core.

INK COMPOSITION AND ELECTRONIC APPARATUS INCLUDING FILM PREPARED USING INK COMPOSITION

Resumen de: US20260297364A1

0000 An ink composition includes: a quantum dot containing at least one organic ligand on a surface thereof; a first monomer containing at least one epoxy group; a second monomer containing at least one oxetane group; a third monomer containing at least one thiol group; and a tertiary amine compound containing at least one allylamine group, where the organic ligand may contain at least one polar moiety. Also, an electronic apparatus including a film prepared from the ink composition is provided.

ANTIBIOLOGICAL SORBENT AND METHOD OF MANUFACTURE THEREOF

Resumen de: US20260295561A1

An antibiological sorbent can include sorbent material (e.g., porous carbon, activated carbon, inorganic carbon, organic carbon, etc.), antibiological material, optionally a functionalizing material, and/or any other suitable material. The antibiological material (and/or the functionalizing material) can coat, intercalate within (e.g., within a porous network of), form structures on, be disposed on, bind to, and/or otherwise be interfaced to the sorbent material.

FUNCTIONALISED NANOPARTICLE

Resumen de: AU2026233972A1

- 1 - A functionalised nanoparticle that is at least in part coated by a polymer comprising charged and uncharged groups at a ratio ranging from 4:1 to 1:4, wherein at 5 least one charged group is a sulfonate group, and at least one pendant functional group is selected from a thiol group and an azide group. The functionalised nanoparticle is conjugatable or can be functionalised to conjugate with a biomolecule. Methods for producing the functionalised 10 nanoparticle and nanoparticle-biomolecule conjugates are also disclosed. - 1 - ep - - e p

USE OF ALGINATE OLIGOMERS TO ENHANCE THE TRANSLOCATION OF MICRO/NANOPARTICLES ACROSS MUCUS LAYERS

Resumen de: US20260295071A1

A micro/nanoparticle formed of self-assembling micro/nanoparticle forming components, wherein at least one self-assembling micro/nanoparticle forming component is a cationic micro/nanoparticle forming component and at least one is an alginate oligomer which has at least 70% mannuronate residues, and the micro/nanoparticle further includes a molecule of interest, optionally wherein the molecule of interest is covalently bound to one or more of the self-assembling micro/nanoparticle forming components. Also disclosed are methods for translocating a cationic micro/nanoparticle across a mucus layer including contacting the mucus layer with at least one alginate oligomer, the alginate oligomer having at least 70% mannuronate residues, together with the cationic micro/nanoparticle; or contacting the cationic micro/nanoparticle with an alginate oligomer having at least 70% mannuronate residues thereby forming a micro/nanoparticle carrying the alginate oligomer, and contacting the mucus layer with the micro/nanoparticle.

INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER

Resumen de: US20260295047A1

0000 The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses.

System and Method for Bilateral Communication Between Humans and Non-Human Animals Using Neural Interfaces

Nº publicación: US20260294321A1 01/10/2026

Solicitante:

QOMPLX LLC [US]
QOMPLX LLC

Resumen de: US20260294321A1

0000 Disclosed embodiments provide a system and method for enabling real-time bilateral neural communication between humans and non-human animals using a combination of non-invasive neural interfaces with optional implantable neural enhancements. Advanced multi-modal pattern recognition algorithms are utilized for real-time neural signal processing, incorporating surface-level sensors and/or enhanced neural monitoring capabilities. These signals are processed through a sophisticated translation unit that converts neural patterns into meaningful communications, while simultaneously providing feedback mechanisms that may deliver precise haptic, auditory, or neural stimulation patterns for reinforcement and response.